GSE125511
ß-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells
ß-caryophyllene (BCP) exhibits anti-proliferative properties in cancer cells.  Here, we examine the hypothesis that BCP induces membrane remodeling.  Our data show that high concentrations of BCP increase membrane permeability of human breast cells (hBrC) causing detachment and cell death.  At a “sub-lethal” concentration of BCP, we show that BCP induces a striking upregulation of genes involved in cholesterol biosynthesis, including the gene that encodes for HMGCoA reductase (HMGCR), the rate-determining step in cholesterol biosynthesis. In addition, stearoyl-CoA desaturase (SCD) is also upregulated which would lead to the enhanced formation of monounsaturated fatty acids, specifically oleate and palmitoleate from stearoyl CoA and palmitoyl CoA, respectively.  These fatty acids are major components of membrane phospholipids and cholesterol esters. Together, these data suggest that cells respond to BCP by increasing the synthesis of components found in membranes.  These responses could be viewed as a repair mechanism and/or as a mechanism to mount resistance to the cytotoxic effect of BCP.  Blocking HMGCR enhances the cytotoxicity of BCP, suggesting that this may provide an additional therapeutic tool in controlling breast cancer cell growth, assuming that targeted specificity could be established. Overall design: Examination of UFH-001 Triple Negative Breast Cancer cell line under hypoxic conditions (control) or in the presence of either 20uM or 200uM beta-caryophyllene (NOTE: The 3 hypoxia controls are duplicates of data submitted to GEO previously as part of another project - GSE123856)